Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
ECB Bancorp, Inc. /MD/ECB Bancorp Reports 6.1% Asset Growth, Net Income Decline in Q3 2024
Ameresco, Inc.Ameresco Reports 49.4% Revenue Growth, Net Income Decline in Q3 2024
COMMUNITY TRUST BANCORP INC /KY/Community Trust Bancorp Reports Strong Q3 2024 Earnings, Loan Growth, and Improved Net Interest Margin
Ivanhoe Electric Inc.Ivanhoe Electric Reports Q3 Financial Results, Revenue Growth, and Strategic Developments
VIRTUS INVESTMENT PARTNERS, INC.Virtus Investment Partners Reports 3.5% Revenue Growth and 23.1% Operating Income Increase in Q3 2024
First Seacoast Bancorp, Inc.First Seacoast Bancorp Reports Improved Financial Performance in Q3 2024
JAKKS PACIFIC INCJAKKS Pacific Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024
SERVOTRONICS INC /DE/Servotronics Reports 7.3% Revenue Growth, Net Loss Narrows in Q3 2024
LanzaTech Global, Inc.LanzaTech Global Reports 49% Revenue Decline, Net Loss Increase in Q3 2024
GRAHAM CORPGraham Corporation Reports 19% Revenue Growth, Net Income Surge in Q2 Fiscal 2025
Smart Powerr Corp.Smart Powerr Corp. Reports Net Loss, Increased Expenses, and Cash Reserves Amid Strategic Shift to Energy Storage Solutions
GraniteShares Gold TrustGraniteShares Gold Trust Reports 12.77% Net Asset Value Increase, Cost of Investment in Gold Bullion Decreases
Uniti Group Inc.Uniti Group Reports Significant Financial Improvements in Q3 2024, Net Income Surges to $12.2 Million
CORPAY, INC.Corpay Reports 6% Revenue Growth, Net Income Increase in Q3 2024
Pulmatrix, Inc.Pulmatrix Reports Decreased Revenue, Improved Losses in Q3 2024, Seeks Additional Funding
GraniteShares Platinum TrustGraniteShares Platinum Trust Reports Decline in Net Assets and Platinum Value in Q3 2024
MYRIAD GENETICS INCMyriad Genetics Reports 11% Revenue Growth, Improved Profitability in Q3 2024
COHEN & STEERS, INC.Cohen & Steers Reports 7.7% Revenue Growth, 23.5% Net Income Increase in Q3 2024
CLOVER HEALTH INVESTMENTS, CORP. /DEClover Health Reports 8.2% Revenue Growth, Improved Net Loss in Q3 2024
ANI PHARMACEUTICALS INCANI Pharmaceuticals Reports 12.5% Revenue Growth, Net Loss in Q3 2024
Monopar TherapeuticsMonopar Therapeutics Reports Continued Losses, Strategic Developments Amid Ongoing Clinical Trials
XPEL, Inc.XPEL Reports 9.9% Revenue Growth and Improved Profitability in Q3 2024
SANDY SPRING BANCORP INCSandy Spring Bancorp Reports Mixed Q3 Results Amid Changing Market Conditions
LANTRONIX INCLantronix Reports 4.2% Revenue Growth, Net Loss in Q3 2024
Holley Inc.Holley Inc. Reports Challenging Financial Performance for 13 and 39 Weeks Ended September 29, 2024